BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8581280)

  • 1. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases.
    Panara MR; Greco A; Santini G; Sciulli MG; Rotondo MT; Padovano R; di Giamberardino M; Cipollone F; Cuccurullo F; Patrono C
    Br J Pharmacol; 1995 Nov; 116(5):2429-34. PubMed ID: 8581280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases.
    Neupert W; Brugger R; Euchenhofer C; Brune K; Geisslinger G
    Br J Pharmacol; 1997 Oct; 122(3):487-92. PubMed ID: 9351505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation.
    Patrignani P; Santini G; Panara MR; Sciulli MG; Greco A; Rotondo MT; di Giamberardino M; Maclouf J; Ciabattoni G; Patrono C
    Br J Pharmacol; 1996 Jul; 118(5):1285-93. PubMed ID: 8818355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs.
    Patrignani P; Panara MR; Sciulli MG; Santini G; Renda G; Patrono C
    J Physiol Pharmacol; 1997 Dec; 48(4):623-31. PubMed ID: 9444611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases.
    Buccellati C; Sala A; Ballerio R; Bianchib M
    Eur J Pain; 2000; 4(4):413-5. PubMed ID: 11124014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
    Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P
    Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production.
    Young JM; Panah S; Satchawatcharaphong C; Cheung PS
    Inflamm Res; 1996 May; 45(5):246-53. PubMed ID: 8737748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
    Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
    Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.
    Patrignani P; Panara MR; Greco A; Fusco O; Natoli C; Iacobelli S; Cipollone F; Ganci A; Créminon C; Maclouf J
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1705-12. PubMed ID: 7996488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat.
    Harada Y; Kawamura M; Hatanaka K; Saito M; Ogino M; Ohno T; Ogino K; Yang Q
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):345-58. PubMed ID: 9653772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
    Burde T; Rimon G
    Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity.
    Rosenstock M; Danon A; Rimon G
    Biochim Biophys Acta; 1999 Aug; 1440(1):127-37. PubMed ID: 10477832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood.
    van Haeringen NJ; van Sorge AA; Van Delft JL; Carballosa Coré-Bodelier VM
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):345-52. PubMed ID: 10977130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
    Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
    J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
    Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
    J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitors.
    Laufer S; Zechmeister P; Klein T
    Inflamm Res; 1999 Mar; 48(3):133-8. PubMed ID: 10219655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nabumetone on prostanoid biosynthesis in humans.
    Cipollone F; Ganci A; Panara MR; Greco A; Cuccurullo F; Patrono C; Patrignani P
    Clin Pharmacol Ther; 1995 Sep; 58(3):335-41. PubMed ID: 7554708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.